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TREATMENT FMI (X) TOTAL 
DISTANCE (μm) 
EUCLIDEAN 
DISTANCE (μm) 
VELOCITY 
(μm/min) 
DIRECTIONALITY 
PBS  0.052 ± 0.036 153.4 ± 35.4 27.1 ± 6.40 0.52 ± 0.12 0.1758± 0.011 
CCL5 -0.089 ± 0.020 267.0 ± 87.7 52.4 ± 16.1 0.91 ± 0.30 0.2036± 0.013 
CCL5 + apoA1   -0.012 ± 0.008* 182.4 ± 58.3 35.8 ± 12.0 0.62 ± 0.20 0.1913± 0.015 
 
Figure 1. Acute pre-treatment with apoA1 inhibits macrophage chemotaxis. Biogel elicited macrophages were incubated with apoA1 (40 mg/ml) for 60
min before being added to the upper chamber (4  105/well) of a CIM-16 plate and allowed to migrate for 7–8 hr toward 10 nM CCL2, CCL5, or C5a.
Figure 1 continued on next page
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Figures and figure supplements
Acute exposure to apolipoprotein A1 inhibits macrophage chemotaxis in vitro and
monocyte recruitment in vivo
Figure 1 continued
Representative traces are shown in panels (A, D, G). Migration was measured with slope (B, E, H) and max-min analysis (C, F, I). Data expressed as
mean + SEM, n = 4–8 biological replicates with 3–4 technical replicates per condition. Statistical analysis was conducted by one-way ANOVA with
Dunnett’s multiple comparison post-test. *p,0.05, **p,0.01, ***p,0.01 relative to CCL2, CCL5, or C5a alone. Biogel elicited macrophages from Cd68-GFP
mice were incubated with either vehicle (J and K) or apoA1 (40 mg/ml) (L) for 60 min before being seeded into ibidim-Slide Chemotaxis3D slides
(1.8  104 cells/chamber). Migration of biogel elicited macrophages in the presence (K and L) or absence (J) of a CCL5 gradient (indicated by the red
triangle) was followed by time-lapse microscopy and quantified by cell tracking. Data for FMI, Euclidean distance, total distance and velocity are
summarised (M) and expressed as mean ± SEM of three independent experiments. Statistical analysis was conducted by an unpaired Students T test.
*p,0.05, CCL5 vs CCL5 + apoA1.
DOI: 10.7554/eLife.15190.003
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Figure 1—figure supplement 1. Short term incubations and different doses of apoA1 inhibit macrophage chemotaxis. Biogel elicited macrophages
were incubated with apoA1 (40 mg/ml) for 60 min before being added to the upper chamber (4  105/well) of a CIM-16 plate and allowed to migrate
for 7–8 hr toward 10 nM chemerin. Representative traces are shown in panel (A). Migration was measured with slope (B) and max-min analysis (C).
Biogel elicited macrophages were pre-incubated with apoA1 (40 mg/ml) for the indicated times before chemotaxis towards 10 nM CCL5. Panel (D)
shows a representative tracing, migration was measured with slope (E) and max-min analysis (F). Biogel elicited macrophages were pre-incubated with
various amounts of apoA1 (20–80 mg/ml) as indicated before chemotaxis towards 10 nM CCL5. Panel (G) shows a representative tracing, migration was
measured with slope (H) and max-min analysis (I). Data are expressed as mean ± SEM, n = 4–8 biological replicates with 3–4 technical replicates per
condition. Statistical analysis was conducted by one-way ANOVA with Dunnett’s multiple comparison post-test. *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001 relative to 10 nM chemerin or CCL5 alone.
DOI: 10.7554/eLife.15190.004
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Figure 2. ApoA1 effects on macrophage chemotaxis are independent of ABCA1, but dependent on cholesterol efflux. Biogel elicited macrophages
from WT, Abca1-/- mice were pre-incubated with apoA1, recombinant apoA1 (rapoA1) or 5-OH-Trp72-rapoA1 (ox-rapoA1) as described in
Materials and methods before measuring chemotaxis towards 10 nM CCL5. Panels (A, D, G) show representative traces, migration was measured with
slope (B, E, H) and max-min analysis (C, F, I). Biogel elicited macrophages from WT mice were pre-incubated with 3 mM methyl b-cyclodextrin (CyD) as
described in Materials and methods before measuring chemotaxis towards 10 nM CCL5. Data are expressed as mean + SEM, n = 4–8 biological
replicates with 3–4 technical replicates per condition. Statistical analysis was conducted by one-way or two-way ANOVA with Dunnett’s multiple
comparison post-test. *p,0.05, **p,0.01, ***p,0.001,****p,0.0001 relative to 10 nM CCL5 alone.
DOI: 10.7554/eLife.15190.005
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PBS  0.037 ± 0.011 142.9 ± 59.1 20.99 ± 7.45 0.3617 ± 0.15 0.1304 ± 0.016 
CCL5 -0.246 ± 0.042 220.7 ± 23.7 87.42 ± 1.43 0.5588 ± 0.06 0.3116 ± 0.041 
CCL5 + apoA1  0.064 ± 0.012** 75.25 ± 1.07*    10.17 ± 5.26 **    0.1905 ± 0.003* 0.1696 ± 0.059*
 
Figure 3. Acute pre-treatment with apoA1 reduces human monocyte chemotaxis. CD14+ selected human monocytes (2  105) were pre-treated with
apoA1 (40 mg/ml) for 60 min before being added to the upper chamber of a CIM-16 plate and allowed to migrate for 2 hr toward 10 nM CCL2, CCL5 or
Figure 3 continued on next page
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Figure 3 continued
C5a. Panels (A, D, G) show representative traces, and migration was measured with slope (B, E, H) and max-min analysis (C, F, I). Data are expressed as
mean + SEM, n = 4 biological replicates with 3–4 technical replicates per condition. Statistical analysis was conducted with one-way ANOVA with
Dunnett’s multiple comparison post-test. *p,0.05, relative to chemoattractant alone. CD14+ selected human monocytes were pre-treated (J and K) with
apoA1 (40 mg/ml) (L) for 60 min before being seeded into ibidi m-Slide Chemotaxis3D slides (1.8  104 cells/chamber). Migration of human monocytes in
the presence (K and L) or absence (J) of a CCL5 (50 nM) gradient (indicated by the red triangle) was followed by time-lapse microscopy and quantified
by cell tracking. Data for FMI, Euclidean distance, total distance, velocity and directness are summarised (M) and expressed as mean ± SEM of two
independent experiments. Statistical analysis was conducted by an unpaired Students T test. *p,0.05, **p,0.05, CCL5 vs CCL5 + apoa1.
DOI: 10.7554/eLife.15190.006
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Figure 3—figure supplement 1. Acute pre-treatment with apoA1 reduces PBMC:HUVEC interactions under flow. Isolated PBMCs (1  106 cells/ml)
were incubated with apoA1 (40 mg/ml) or buffer (control) for 60 min prior to perfusion over TNF-a stimulated HUVECs. Panel (A) are representative
images of PBMC:HUVEC interactions following treatment with apoA1 vs control (Scale bar 20 mm). PBMC (B) rolling, (C) adhesion and (D) transmigration
were quantified from six random fields/treatment. Results are expressed as percentage of control of two independent experiments. Statistical analysis
was conducted with Mann-Whitney U test. 650 *p,0.05, versus control; n = 4 donors. (A) Human CD14+ monocytes were isolated (1  106) and pre-
treated with apoA1 (40 mg/ml) for 60 min before being stimulated with 10 nM C5a for 5 min. Representative histograms from flow cytometry for (E)
CD14, (F) CD62L, (G) CD49b, (H) active CD11b, (I) total CD11b and (J) C5aR1 expression levels are shown from a total of four independent donors.
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Figure 4. Acute exposure to apoA1 reduces the recruitment of adoptively transferred monocytes to sites of
inflammation in vivo. Diagram of the experimental design presented in (A). Monocytes were isolated from Cd68-
GFP bone marrow using ‘no-touch’ negative immunomagnetic selection (B). Isolated monocytes were
characterized as 7/4high/Ly6Glow, with a typical yield of 65–70% monocytes, of which 70–80% were GFP positive.
Isolated Cd68-GFP monocytes (1  106) treated for 45 min with either apoA1 (40 mg/ml) or PBS and were
adoptively transferred into C57BL/6J mice by i.v. injection 30 min after i.p. injection with 100 mg zymosan. Mice
were euthanized at 16 hr, and peritoneal lavage and blood samples were collected. Representative flow cytometry
plots of peritoneal lavage from C57BL/6J mice that received adoptively transferred GFP positive monocytes
treated with or without apoA1 during ongoing zymosan-induced peritonitis (C). Total monocytes and total
adoptively transferred GFP+ monocytes were quantified in peritoneal lavage (D–E) and blood (F–G). Data are
expressed as mean + SEM of 8–10 mice from two independent experiments. Statistical analysis was conducted by
paired Students T test. **p,0.01, relative to control.
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Figure 4—figure supplement 1. Acute exposure to apoA1 reduces the recruitment of adoptively transferred CD45.1 monocytes to sites of
inflammation in CD45.2 recipient mice. (A) Diagram of the experimental design. (B) Monocytes were isolated from SJL/1 mice (CD45.1 positive) bone
marrow using ‘no-touch’ negative immunomagnetic selection. Isolated monocytes were characterized as 7/4high/Ly6Glow, with a typical yield of 65–70%
monocytes. A total of 1  106 isolated CD45.1+ monocytes treated with either apoA1 (40 mg/ml) for 60 min or PBS were adoptively transferred into
C57BL/6J mice (CD45.2 positive) by i.v. injection 30 min after i.p. injection with 100 mg zymosan. Mice were euthanized at 16 hr, and peritoneal lavage
and blood samples were taken. (B–E) Total monocytes and total adoptively transferred CD45.1+ monocytes were quantified in peritoneal lavage and
blood. Data are expressed as mean ± SEM of 8–10 mice from two independent experiments. Statistical analysis was conducted by paired Students T
test. **p<0.01, relative to control.
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Figure 5. Apoa1Tg mice display reduced leukocyte recruitment in zymosan peritonitis. Apoa1Tg and WT control
mice were injected i.p. with 100 mg zymosan. Mice were euthanized at 16 hr and peritoneal lavage samples were
collected. Representative flow cytometry plots are shown in panel (A) of neutrophils (Neut) characterised as
CD45+/CD115-/Ly6G+ and monocytes characterised as CD45+/CD115+/Ly6Chi/lo from peritoneal lavage fluid. Total
cells (B), neutrophils (C) total monocytes (D), Ly6Chi monocytes (E), Ly6Clo monocytes (F) within the peritoneal
Figure 5 continued on next page
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Figure 5 continued
cavity following zymosan challenge are expressed. (G) Total circulating blood white cell counts from Apoa1Tg
mice and WT controls are expressed as mean ± SEM of 3–9 mice per condition. (H–J) CXCL1 and CCL2 levels
were measured in peritoneal lavage fluid by ELISA. Data are expressed as mean + SEM of 2–6 mice per genotype
of two independent experiments. Statistical analysis was conducted by one-way ANOVA with Dunnett’s multiple
comparison post-test. *p,0.05, **p,0.01 compared to WT.
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Figure 6. ApoA1 suppresses Akt signalling and PI3K activity following chemokine activation of human and murine
monocyte-derived cells. CD14+ selected human monocytes or biogel elicited murine macrophages (2  105) were
pre-incubated with either vehicle (PBS), apoA1 (40 mg/ml) or 3 mM methyl b-cyclodextrin (CyD) for 60 min as
described in Materials and methods. Human CD14+ monocytes (A) or murine macrophages (B,C) were then
stimulated with either 10 nM C5a or CCL5. Relative levels of phosphorylated Akt were determined by Western
blotting. Representative blots from independent biological replicates are shown. Densitometry of western blots is
shown in panels below representative western blots (n > 2/group). Data are expressed as mean ± SEM, n = 2–6
biological replicates. Murine RAW macrophages were pre-incubated with apoA1 (40 mg/ml) or vehicle for 60 min
at 37˚C, 5% CO2 prior to stimulation with C5a (10 nM) for 10 min (D). PI3K was immunoprecipitated from cell
lysates and PI3K activity determined by incubating with PIP2 and measuring PIP3 production by competitive ELISA.
Data are expressed as mean + SD, n = 4 independent experiments. Statistical analysis was conducted by one-way
ANOVA with Dunnett’s multiple comparison post-test. *p<0.05, relative to C5a alone. Biogel elicited
macrophages were incubated with 100 nM wortmannin for 60 min before being added to the upper chamber
(4  105/well) of a CIM-16 plate and allowed to migrate for 8 hr at 37˚C, 5% CO2 towards 10 nM CCL5.
Representative traces are shown in panel (E). Migration was measured by max-min analysis (F). Statistical analysis
was conducted by one-way ANOVA with Dunnett’s multiple comparison post-test. *p<0.05, ***p<0.001 relative to
CCL5 alone.
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Figure 6—figure supplement 1. Gai/o-signalling, b-arrestin recruitment and intracellular Ca
2+ flux remain unaffected in response to apoA1. (A)
Intracellular cAMP levels were measured as described in Supplemental Methods in CHO-K1 cells expressing human C5aR1. Cells were incubated as
described in Materials and methods with either vehicle or apoA1 (40 mg/ml) as indicated. Following treatment, vehicle or C5a was added in assay buffer
containing forskolin (FSK: 20 mM final assay concentration) to give the indicated final concentrations. The cells were then incubated for 30 min before
the addition of the detection reagents. Data are mean ± SEM, n = 3. (B) Recruitment of b-Arrestin was measured as described in Supplemental
Methods in CHO-K1 cells expressing murine CCR2. Cells were incubated as described in Materials and methods with either vehicle or apoA1 as
indicated. Following treatment, vehicle or CCR2 was added and cells incubated for 90 min before the addition of the detection reagents. Data are
mean ± SEM, n = 3. Biogel elicited macrophages were loaded with FURA2-AM in the presence or absence of 40 mg/ml apoA1 for 45 min. Macrophages
were then stimulated with either vehicle or 10 nM C5a. (C) Representative tracings of intracellular Ca2+ levels following C5a stimulation in vehicle or
apoA1 pre-treated cells. (D) Pre-treatment with apoA1 has no effect on intracellular Ca2+ levels. Data are mean ± SEM, n = 4 biological replicates.
Statistical analysis was performed by two-way ANOVA with Sidak’s multiple comparisons correction.
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Figure 7. ApoA1 modulates monocyte-derived cell lipid raft cholesterol content in cells of murine and human origin. (A–B) Total cell caveolin-1 was
assessed by Western blotting following treatment of biogel elicited macrophages with apoA1 (40 mg/ml), ox-rapoA1 (40 mg/ml) or 3 mM methyl b-
cyclodextrin (CyD) for 1 hr. The lipid raft content of biogel elicited macrophages was assessed following treatment with apoA1 (40 mg/ml) or 3 mM CyD
for 1 hr, and incubation of the cells with cholera toxin B Alexa Fluor 647 conjugate to bind lipid raft ganglioside G M1. Relative fluorescence (compared
to PBS-treated control cells) was assessed by flow cytometry (C), and cells were imaged by confocal microscopy (D–F). Prior to fractionation of
membrane lipid rafts, human THP-1 macrophages were treated with either vehicle, apoA1 (40 mg/ml), ox-rapoA1 (40 mg/ml), or 3 mM CyD for 1 hr prior
to stimulation with 10 nM CCL5 for 5 min. Cells were then homogenized in a 0.2% Triton-X 100 containing buffer prior to 5–45% sucrose density
gradient centrifugation. Fractions were collected from the top (fraction 1, lightest fraction) to the bottom (fraction 10, heaviest fraction), and fraction
proteins separated by SDS-PAGE, transferred to PVDF membranes and caveolin-1, flotillin-1, or transferrin receptor (TfR) content assessed by western
blotting. Representative distribution of raft and non-raft marker proteins presented in panel (G). The cholesterol content of each fraction was
determined via the amplex red assay, with a representative distribution shown in panel (H). The sums of the cholesterol content in lipid raft fractions
(fractions 2–4), and non-raft fractions (fractions 8–10) following treatment with apoA1, ox-rapoA1 and CyD are shown in panels (I) and (J), respectively.
Western blots are representative of three independent experiments. Cholesterol contents are means + SEM of three independent experiments.
Statistical analysis was conducted by one-way ANOVA with Dunnett’s multiple comparison post-test. *p<0.05, **p<0.01 relative to PBS.
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Figure 7—figure supplement 1. ApoA1 depletes membrane lipid rafts of cholesterol in cholesterol-loaded THP-1 cells. Human THP-1 macrophages
were incubated with methyl-b-cyclodextrin:cholesterol complexes (0.5 mg/mL) for 1 hr to cholesterol-load cells prior to incubation for 1 hr with 40 mg/
mL apoA1 or PBS. Cells were then homogenized in a 0.2% Triton-X 100 containing buffer prior to 5–45% sucrose density gradient centrifugation.
Fractions were collected from the top (fraction 1, lightest fraction) to the bottom (fraction 10, heaviest fraction), and cholesterol content of each fraction
quantified. The sums of the cholesterol content in lipid raft fractions (fractions 2–4), and non-raft fractions (fractions 8–10), are shown in panels (A) and
(B) respectively. Statistical analysis was conducted by using Student’s T test. *p<0.05 relative to loaded cells alone.
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